NCT04521439View on ClinicalTrials.gov

Accurate Diagnosis of Multiple Sclerosis Using PET/MR

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

March 30, 2022

Study Completion Date

July 30, 2022

Conditions
Multiple Sclerosis
Interventions
DIAGNOSTIC_TEST

18F-florbetapir PET+MRSI

PET and MRS quantitative parameters in MS lesions are simultaneously analyzed using hybrid PET/MR for obtaining demyelination and neuronal damage information.

Trial Locations (1)

200025

Shanghai Ruijin Hospital, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER

NCT04521439 - Accurate Diagnosis of Multiple Sclerosis Using PET/MR | Biotech Hunter | Biotech Hunter